1. Home
  2. KMDA vs APEI Comparison

KMDA vs APEI Comparison

Compare KMDA & APEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • APEI
  • Stock Information
  • Founded
  • KMDA 1990
  • APEI 1991
  • Country
  • KMDA Israel
  • APEI United States
  • Employees
  • KMDA N/A
  • APEI N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • APEI Other Consumer Services
  • Sector
  • KMDA Health Care
  • APEI Consumer Discretionary
  • Exchange
  • KMDA Nasdaq
  • APEI Nasdaq
  • Market Cap
  • KMDA 443.4M
  • APEI 453.1M
  • IPO Year
  • KMDA N/A
  • APEI 2007
  • Fundamental
  • Price
  • KMDA $7.72
  • APEI $30.33
  • Analyst Decision
  • KMDA Strong Buy
  • APEI Buy
  • Analyst Count
  • KMDA 2
  • APEI 6
  • Target Price
  • KMDA $13.00
  • APEI $31.60
  • AVG Volume (30 Days)
  • KMDA 55.4K
  • APEI 351.8K
  • Earning Date
  • KMDA 08-13-2025
  • APEI 08-05-2025
  • Dividend Yield
  • KMDA 2.59%
  • APEI N/A
  • EPS Growth
  • KMDA 31.21
  • APEI N/A
  • EPS
  • KMDA 0.28
  • APEI 1.02
  • Revenue
  • KMDA $167,235,000.00
  • APEI $634,678,000.00
  • Revenue This Year
  • KMDA $14.51
  • APEI $7.28
  • Revenue Next Year
  • KMDA $9.31
  • APEI $4.10
  • P/E Ratio
  • KMDA $28.31
  • APEI $29.84
  • Revenue Growth
  • KMDA 11.83
  • APEI 4.86
  • 52 Week Low
  • KMDA $5.08
  • APEI $11.80
  • 52 Week High
  • KMDA $9.16
  • APEI $32.24
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 53.97
  • APEI 53.22
  • Support Level
  • KMDA $7.64
  • APEI $29.02
  • Resistance Level
  • KMDA $7.91
  • APEI $31.40
  • Average True Range (ATR)
  • KMDA 0.18
  • APEI 1.20
  • MACD
  • KMDA -0.02
  • APEI -0.20
  • Stochastic Oscillator
  • KMDA 50.00
  • APEI 40.68

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About APEI American Public Education Inc.

American Public Education Inc provides online and campus based postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.

Share on Social Networks: